PARATEK PHARMACEUTICALS INC's ticker is PRTK and the CUSIP is 699374302. A total of 90 filers reported holding PARATEK PHARMACEUTICALS INC in Q2 2019. The put-call ratio across all filers is - and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2022 | $0 | – | 86 | 0.0% | 0.00% | – |
| Q2 2022 | $0 | – | 86 | 0.0% | 0.00% | – |
| Q1 2022 | $0 | – | 86 | 0.0% | 0.00% | – |
| Q4 2021 | $0 | – | 86 | 0.0% | 0.00% | – |
| Q3 2021 | $0 | -100.0% | 86 | 0.0% | 0.00% | – |
| Q2 2021 | $1,000 | 0.0% | 86 | 0.0% | 0.00% | – |
| Q1 2021 | $1,000 | 0.0% | 86 | 0.0% | 0.00% | – |
| Q4 2020 | $1,000 | 0.0% | 86 | -50.3% | 0.00% | – |
| Q3 2019 | $1,000 | 0.0% | 173 | 0.0% | 0.00% | – |
| Q2 2019 | $1,000 | 0.0% | 173 | 0.0% | 0.00% | – |
| Q1 2019 | $1,000 | 0.0% | 173 | 0.0% | 0.00% | – |
| Q4 2018 | $1,000 | -50.0% | 173 | 0.0% | 0.00% | – |
| Q3 2018 | $2,000 | 0.0% | 173 | 0.0% | 0.00% | – |
| Q2 2018 | $2,000 | 0.0% | 173 | 0.0% | 0.00% | – |
| Q1 2018 | $2,000 | – | 173 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Omega Fund Management, LLC | 2,600,410 | $13,340,000 | 9.89% |
| Abingworth LLP | 1,041,131 | $5,341,000 | 4.85% |
| Roumell Asset Management, LLC | 450,406 | $2,311,000 | 4.78% |
| HIGHLAND CAPITAL MANAGEMENT LP | 2,391,993 | $12,271,000 | 0.94% |
| Trellus Management Company, LLC | 71,200 | $365,000 | 0.82% |
| ARMISTICE CAPITAL, LLC | 1,968,000 | $10,096,000 | 0.76% |
| Arbiter Partners Capital Management LLC | 1,111,936 | $5,704,000 | 0.64% |
| Fortress Investment Group LLC | 433,804 | $2,226,000 | 0.27% |
| GENERAL AMERICAN INVESTORS CO INC | 464,985 | $2,385,000 | 0.25% |
| WATER ISLAND CAPITAL LLC | 318,518 | $1,634,000 | 0.12% |